We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Penske Automotive Group
PAG
$14.1B
| $276K | ﹤0.01% |
1,855
-488
| -21% | -$74.2K |
|
1427
Allegion
ALLE
$13B
| $275K | ﹤0.01% |
2,325
-3,643
| -61% | -$449K |
|
1428
Carrier Global
CARR
$44.7B
| $271K | ﹤0.01% |
4,294
-143
| -3% | -$8.78K |
|
1429
Ibotta
IBTA
$838M
| $271K | ﹤0.01% |
+3,600
| New | +$335K |
|
1430
Ormat Technologies
ORA
$5.65B
| $265K | ﹤0.01% |
3,690
+14
| +0.4% | +$972 |
|
|
PFC
1431
DELISTED
Premier Financial Corp. Common Stock
PFC
| $263K | ﹤0.01% |
12,864
-251
| -2% | -$4.99K |
|
1432
ProPetro Holding
PUMP
$1.25B
| $259K | ﹤0.01% |
29,912
+2,446
| +9% | +$21.8K |
|
1433
Helen of Troy
HELE
$634M
| $259K | ﹤0.01% |
2,790
-1,076
| -28% | -$109K |
|
1434
Expensify
EXFY
$210M
| $258K | ﹤0.01% |
173,150
+5,077
| +3% | +$8K |
|
1435
Axcelis
ACLS
$3.2B
| $257K | ﹤0.01% |
1,810
-11,463
| -86% | -$1.32M |
|
|
PAL
1436
Proficient Auto Logistics
PAL
$134M
| $257K | ﹤0.01% |
+16,000
| New | +$244K |
|
1437
Kaiser Aluminum
KALU
$2.49B
| $256K | ﹤0.01% |
+2,918
| New | +$272K |
|
1438
International Flavors & Fragrances
IFF
$21.5B
| $255K | ﹤0.01% |
2,677
-209
| -7% | -$19.2K |
|
1439
CDW
CDW
$18.7B
| $255K | ﹤0.01% |
1,137
+533
| +88% | +$124K |
|
1440
Sempra
SRE
$53.4B
| $249K | ﹤0.01% |
3,275
-87
| -3% | -$6.43K |
|
|
SCWX
1441
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $247K | ﹤0.01% |
35,241
| – | – |
|
|
HOLX
1442
DELISTED
Hologic
HOLX
| $246K | ﹤0.01% |
+3,313
| New | +$248K |
|
1443
Insperity
NSP
$1.97B
| $246K | ﹤0.01% |
2,693
-173
| -6% | -$17.5K |
|
1444
1-800-Flowers.com
FLWS
$174M
| $244K | ﹤0.01% |
25,633
+2,100
| +9% | +$19.7K |
|
1445
Arthur J. Gallagher & Co
AJG
$62.5B
| $244K | ﹤0.01% |
940
-17,787
| -95% | -$4.41M |
|
1446
SFL Corp
SFL
$1.87B
| $242K | ﹤0.01% |
17,425
-365
| -2% | -$4.94K |
|
1447
Carnival Corporation Ltd
CCL
$30.6B
| $241K | ﹤0.01% |
12,879
+55
| +0.4% | +$850 |
|
1448
RH
RH
$2.4B
| $240K | ﹤0.01% |
982
-808
| -45% | -$212K |
|
1449
Edison International
EIX
$21.1B
| $239K | ﹤0.01% |
3,326
+1,556
| +88% | +$113K |
|
1450
Sagimet Biosciences
SGMT
$650M
| $233K | ﹤0.01% |
68,000
+14,000
| +26% | +$64.2K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.